AES Press Releases
Epilepsy New Drug Expert, Former Federal Epilepsy Program Head, to Receive the American Epilepsy Society’s 2013 Service Award
Epilepsy New Drug Expert, Former Federal Epilepsy Program Head,
to Receive the American Epilepsy Society’s 2013 Service Award
West Hartford, Conn., December 6, 2013– Roger J. Porter, M.D., a consultant in epilepsy new drug and device development and former Deputy Director of the National Institute of Neurological Disorders and Stroke (NINDS), has been named recipient of the American Epilepsy Society’s (AES) 2013 Service Award. Dr. Porter has a long and distinguished career in research on epilepsy drug discovery and development of advanced technology in seizure control. He also has a long record of voluntary service with national professional and lay organizations concerned with epilepsy, including a term as AES president and later as secretary-general of the International League Against Epilepsy (ILAE).
The AES Service Award recognizes Dr. Porter for his contributions in the field of epilepsy and service to AES and its members. In addition to his term on the AES board of directors, he has been a member of the Society’s anticonvulsant development task force, several clinical investigator workshops, and corporate advisory committee. He has been active with the Epilepsy Therapy Development Project, and currently serves as the chief scientific officer of the Epilepsy Foundation. This year’s Service Award will be presented December 6th during the AES 67th annual meeting and scientific conference at the Washington, DC, Convention Center.
Prior to leaving NINCDS, Dr. Porter had chaired a White House Committee on Brain and Behavioral Sciences. He is past-president of the American Society of Experimental Neurologic Therapeutics, past-secretary of the College of Physicians of Philadelphia, and a Fellow of the American Academy of Neurology. He has been a consultant-lecturer for the National Naval Medical Center, and today holds adjunct professorships at the Uniformed Services University of the Health Sciences, Bethesda, MD, and at the University of Pennsylvania.
In announcing the award, John Huguenard, Ph.D., who chairs the AES awards committee, said, “Roger has contributed more to the development of the new generation of epilepsy drugs than perhaps anyone. He was a key figure in the federal antiepileptic drug-screening program that has brought so much improvement in the lives of today’s epilepsy patients. Moreover, he has been extraordinarily generous in the time and energy he has given not only to AES, but to the epilepsy community at large. Through both his research, teaching and extensive volunteer activity, he has been a major contributor to our understanding and treatment of epilepsy.”
The epilepsies affect 50 million people worldwide, including three million in the United States. The disorder can have a single specific, well-defined cause, such as a head injury, or manifest as a syndrome with a complex of symptoms. It is the third most common neurological disorder after Alzheimer’s disease and stroke.
About the American Epilepsy Society (AES)
The American Epilepsy Society, based in West Hartford, Conn., seeks to advance and improve the treatment of epilepsy through the promotion of epilepsy research and education for healthcare professionals. Society membership includes physicians and scientists who study and treat epilepsy (epileptologists) and allied professionals who care for people with seizure disorders.
Peter Van Haverbeke, AES Media Relations, cell 703-927-9639
Natalie Judd, Big Voice Communications, cell 203-605-9515, office 203-389-5223
203.389.5223 - email@example.com